New Strategy for Avoiding Waste and Improving Response for Highest Cost Therapies in Rheumatoid Arthritis

Scipher Medicine Announces Publication of Clinical Study Validating PrismRA, a Blood Test Predicting Non-Response to TNF Inhibitor Therapies in Patients with Rheumatoid Arthritis

Pandemic versus pandemonium: fighting on two fronts

COVID-19 might be bitter medicine for what ails AI investing

Coronavirus: AI steps up in battle against Covid-19

Scipher Medicine has developed a blood test expected to save payers billions each year

Defining response to TNF-inhibitors in rheumatoid arthritis: the negative impact of anti-TNF cycling

Scipher: Decoding Drug Response From Protein Interactions

Getting Personal With Precision Medicine

Bringing Precision Medicine to Autoimmune Diseases

How Precision Medicine Can Change the Drug Pricing Conversation

How A Blood Test Can Disrupt A $20B Market